177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study
Condition(s):Metastatic Prostate CancerLast Updated:February 12, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Prostate CancerLast Updated:February 12, 2024Completed
Condition(s):Prostate Cancer; Metastatic Castration-resistant Prostate Cancer; Biochemically Recurrent Prostate CarcinomaLast Updated:January 29, 2024Not yet recruiting
Condition(s):Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Adenocarcinoma; Stage IV Prostate Cancer; Stage IVA Prostate Cancer; Stage IVB Prostate CancerLast Updated:January 29, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:November 17, 2017Unknown status
Condition(s):Prostate Cancer; mCRPCLast Updated:February 22, 2024Recruiting
Condition(s):Prostatic NeoplasmsLast Updated:February 6, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:October 9, 2017Unknown status
Condition(s):Recurrent Prostate CancerLast Updated:March 17, 2023Recruiting
Condition(s):Prostate CancersLast Updated:August 22, 2017Withdrawn
Condition(s):Castrate-Resistant Prostate CancerLast Updated:July 17, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.